Shuwen Fu
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 7
- Molecular Medicine top 10%
-
- Nanoplatforms for cancer theranostics 10
- Graphene and Nanomaterials Applications 2
- Innovative Microfluidic and Catalytic Techniques Innovation 1
- Pharmaceutical Science top 10%
-
- Cancer therapeutics and mechanisms 3
- Advanced biosensing and bioanalysis techniques 2
-
- Porphyrin and Phthalocyanine Chemistry 3
-
- Photodynamic Therapy Research Studies 3
- Co-authors
- Yinglei ZhaiGuanting LiXinyu ZhouKexin ShiKaiyu LiMohan LiJing YeWei Sun
- Journals
- Acta Pharmaceutica Sinica B (1 paper)Chemical Communications (1 paper)Chinese Chemical Letters (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Shuwen Fu
15 papers receiving 393 citations
Peers
Comparison fields: 5 of 75
- Biomaterials 159
- Molecular Medicine 47
- Biomedical Engineering 210
- Pharmaceutical Science 29
- Rehabilitation 14
Countries citing papers authored by Shuwen Fu
This map shows the geographic impact of Shuwen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuwen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuwen Fu more than expected).
Fields of papers citing papers by Shuwen Fu
This network shows the impact of papers produced by Shuwen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuwen Fu. The network helps show where Shuwen Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuwen Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 19 | |
| 14 | 2021 | 184 | |
| 15 | 2021 | 27 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 77 |
About Shuwen Fu
Shuwen Fu is a scholar working on Biomaterials, Biomedical Engineering and Otorhinolaryngology, having authored 17 papers that have together received 397 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (7 papers), Cancer therapeutics and mechanisms (3 papers), Porphyrin and Phthalocyanine Chemistry (3 papers), Photodynamic Therapy Research Studies (3 papers), Graphene and Nanomaterials Applications (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). The work is most often cited by research in Biomaterials (159 citations), Molecular Medicine (47 citations) and Biomedical Engineering (210 citations). Shuwen Fu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yinglei Zhai, Guanting Li, Xinyu Zhou, Kexin Shi, Kaiyu Li, Mohan Li, Jing Ye, Wei Sun, Zhonggui He and Jin Sun. Their work appears in journals such as Acta Pharmaceutica Sinica B, Chemical Communications, Chinese Chemical Letters, Advanced Healthcare Materials and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.